These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33800013)

  • 1. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
    Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural-based virtual screening and
    Ibrahim IM; Elfiky AA; Mahmoud SH; ElHefnawi M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9145-9158. PubMed ID: 37615430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
    Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
    Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
    Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
    Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.
    White MA; Lin W; Cheng X
    J Phys Chem Lett; 2020 Nov; 11(21):9144-9151. PubMed ID: 33052685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
    Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
    Di Paco G; Macchiagodena M; Procacci P
    ChemMedChem; 2024 May; 19(10):e202400095. PubMed ID: 38456332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase.
    Abidi SH; Almansour NM; Amerzhanov D; Allemailem KS; Rafaqat W; Ibrahim MAA; la Fleur P; Lukac M; Ali S
    Sci Rep; 2021 May; 11(1):10290. PubMed ID: 33986405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.
    Vivek-Ananth RP; Krishnaswamy S; Samal A
    Mol Divers; 2022 Feb; 26(1):429-442. PubMed ID: 34117992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.
    Thomas J; Ghosh A; Ranjan S; Satija J
    Sci Rep; 2024 Apr; 14(1):9801. PubMed ID: 38684706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
    Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
    Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
    El Hassab MA; Ibrahim TM; Al-Rashood ST; Alharbi A; Eskandrani RO; Eldehna WM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):727-736. PubMed ID: 33685335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided Design of Wide-spectrum Coronavirus Helicase NSP13 Cage Inhibitors: A Molecular Modelling Approach.
    Shiryaev V; Klimochkin Y
    Curr Comput Aided Drug Des; 2024; 20(7):1027-1041. PubMed ID: 37921184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
    Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
    Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
    Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.